Log In
BCIQ
Print this Print this
 

Nexvax2

  Manage Alerts
Collapse Summary General Information
Company ImmusanT Inc.
DescriptionVaccine composed of 3 gluten peptides
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationCeliac disease
Indication DetailsTreat celiac disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/21/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today